Novartis Patient Assistance Foundation (NPAF) NPAF is an independent 501(c)(3) non-profit organization that provides Novartis medications free of cost to eligible patients who have limited or no prescription insurance coverage and cannot afford the cost of their medication. ...
At Novartis, we are united by a single purpose to reimagine medicine to improve and extend people’s lives.Drug delivery, service delivery, and the future of cancer care State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in phar...
In, EffectivenessSupport, PatientStrategy, MitigationBermangorvine, By Martin
Just as Novartis has delayed an FDA filing in prostate cancer, Exelixis is also awaiting more mature overall survival data for a combination of its Cabometyx and Roche's Tecentriq to submit an application. (Exelixis) Another prostate cancer trial has hit its main goal, and y...
United States Patent Application 20150004191 Kind Code: A1 Abstract: Conjugated capsular saccharides from meningococcal serogroups C, W135 and Y are safe and immunogenic in humans when combined in a single dose. This effect is retained when a conjugated capsular saccharide from serogroup A is added....
United States Patent Application 20180036315 Kind Code: A1 Abstract: The present invention relates to an oxazine derivative BACE-1 inhibitor and pharmaceutical compositions comprising such oxazine derivative for use in the prevention of Alzheimer's disease in a patient at risk of developing clinical ...
This application claims the benefit of U.S. Provisional Application No. 62/545,907, filed Aug. 15, 2017, the entire contents of which are incorporated by reference. Claims: What is claimed is: 1.A cannula for use in ophthalmic surgical procedures comprising:a tubular section defining a passa...